Abstract
Introduction
This pilot study investigated the effects of a 12-week administration of a nutritional supplement containing special collagen peptides on the structural and molecular properties of the collagen fiber network in the human skin. For the assessments, the suction blister method and electron microscopical comparisons were used.
Methods
Three suction blisters were generated on the inner forearm of each test subject before and after the 12-week administration of the nutritional supplement. High-resolution scanning electron microscopy (SEM) was employed to meticulously investigate the structural characteristics of the skin’s collagen network, including the length and diameter of collagen fibers within the suction blister roof. Furthermore, the analysis included immunohistochemistry and fluorescence light microscopy to study hyaluronic acid within the extracellular matrix. Additional assessments encompassed changes in various epidermal parameters. Nine female participants within the age range of 43.7–61.8 years (mean: 52.5 ± 5.9 years) completed the study in accordance with the study protocol.
Results
Compared with baseline, the 12-week supplementation regimen led to a statistically significant average increase in the collagen fiber network size of 34.56% (p < 0.0001). Additionally, collagen fiber cross-linking and fiber length were substantially increased. The ingestion of the supplement also resulted in an 18.08% elevation in epidermal hyaluronic acid concentration (p < 0.0001). No adverse events were recorded during the study.
Conclusion
Using an innovative approach, this study demonstrated the ability of a targeted nutritional supplement to effectively restore the ultrastructural integrity of the dermal collagen network, which is typically disrupted by the natural aging process of the skin. These findings not only corroborate existing data regarding the positive effects of oral collagen peptides on skin structure and function but also contribute to our understanding of ultrastructural morphological aspects of changes in the skin’s collagen network. Supplementation can induce regeneration of the collagen fiber network in the human skin.
Trial Registration Number
German Clinical Trials Register, DRKS-ID DRKS00034161- Date of registration: 06.05.2024, retrospectively registered.
Plain Language Summary
Is it possible to improve the structure and molecular properties of the collagen fiber network in human skin by taking collagen peptides orally? To find out, suction blisters were created on the inner forearm of nine women before and after taking a nutritional supplement containing special collagen peptides for 12 weeks. To detect changes in the collagen fiber network, the inner surfaces of the roofs of the isolated suction blisters were examined using scanning electron microscopy. Additionally, hyaluronic acid levels were measured with fluorescence light microscopy. As a result, it was shown for the first time that a 12-weeks supplement regimen can lead to a statistically significant increase in the size of the collagen fiber network. Moreover, collagen fiber cross-linking and fiber length were substantially increased. The supplement also led to a statistically significant rise in epidermal hyaluronic acid levels. These findings not only support existing data on the positive effects of oral collagen peptides on skin structure and function but also enhance our understanding of the detailed morphological changes in the skin’s collagen network.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Microscopy Services Dähnhardt GmbH, Flintbek, Germany (GRID:grid.518937.1)
2 SGS INSTITUT FRESENIUS GmbH, Hamburg, Germany (GRID:grid.425324.6)
3 QUIRIS Healthcare GmbH & Co. KG, Gütersloh, Germany (GRID:grid.492097.1)





